StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Allergan (AGN), Richter Update on Cariprazine; MD-72 Adjunctive MDD Trial Data Said Not Significant
August 5, 2016 6:50 AM
Allergan plc (NYSE: AGN) and Gedeon Richter Plc., provided a clinical and regulatory update on cariprazine. For more than a ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Corporate News
FDA
Hot Corp. News
Management Comments
Next Articles
Piper Jaffray Remains Sidelined on Allergan (AGN) Following Mixed 2Q
August 9, 2016 9:08 AM
Allergan and Richter Provide Update on Cariprazine Program
August 5, 2016 2:00 AM